Trial Profile
Stiripentol for the treatment of pharmacoresistant epilepsy with drug eruptions
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 28 May 2020
Price :
$35
*
At a glance
- Drugs Stiripentol (Primary) ; Antiepileptic drugs
- Indications Epilepsy
- Focus Therapeutic Use
- 29 Nov 2018 New trial record